Log in to save to my catalogue

Meta-Analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity

Meta-Analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2183980315

Meta-Analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity

About this item

Full title

Meta-Analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity

Publisher

United States: Elsevier Inc

Journal title

The American journal of cardiology, 2018-12, Vol.122 (11), p.1959-1964

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Anthracycline is a commonly prescribed antineoplastic agent. As a consequence of the growing number of cancer survivors, the incidence of anthracycline-induced cardiotoxicity is increasing. However, the optimal primary preventive strategy is lacking. Therefore, we conducted a meta-analysis of all randomized controlled trials to evaluate the efficac...

Alternative Titles

Full title

Meta-Analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2183980315

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2183980315

Other Identifiers

ISSN

0002-9149

E-ISSN

1879-1913

DOI

10.1016/j.amjcard.2018.08.039

How to access this item